Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report View Sample

Published: August 25, 2022 Report Code: GDME1429EPD-ST

Select Item

Infusion Systems are used for drug infusion and pain management. The infusion systems pipeline market research report provides comprehensive information about the infusion systems pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report also provides key insights on major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.

Key Segments in Infusion Systems Pipeline Products Market

Infusion pumps, implantable infusion pumps, syringe pumps, infusion disposable sets, volumetric pumps, ambulatory infusion pumps, disposable ambulatory infusion pumps, PCA syringe pumps, and reusable ambulatory infusion pumps are the key segments covered in the infusion systems pipeline market research report. Infusion pumps hold the largest market share.

Infusion Systems Pipeline Products Market, by Segments

Infusion Systems Pipeline Products Market, by Segments

For more segment insights, download a free report sample

Key Regions for the Infusion Systems Pipeline Products Market

United States, Europe, Israel, Japan, New Zealand, Singapore, South Africa, United Kingdom, Australia, Canada, Chile, Colombia, Ecuador, Brazil, Argentina, and Mexico have products in the pipeline. As of August 2022, the US has the highest number of products in the pipeline out of all these territories.

Infusion Systems Pipeline Products Market, Regional Outlook

Infusion Systems Pipeline Products Market, Regional Outlook

For more territorial insights, download a free report sample

Key Regulatory Paths for the Infusion Systems Pipeline Products Market

The regulatory paths followed by the infusion systems pipeline products include 510(k), CE, TGA, PMA, UKCA, HSA, MDL, Ninsho, INVIMA, de Novo, and ANVISA. Most of the products follow the 510(k) pathway to enter the market.

Infusion Systems Pipeline Products Market, by Regulatory Path

Infusion Systems Pipeline Products Market, by Regulatory PathFor more regulatory path insights, download a free report sample

Key Companies in the Infusion Systems Pipeline Products Market

Some of the key companies in the infusion systems pipeline products market are Adept Medical Ltd, Albireo Pharma Inc, Alnylam Pharmaceuticals Inc, AngioDynamics Inc, Arnali, LLC, Massachusetts Institute of Technology, Medical Device Creations Ltd., Medovate Ltd, Unilife Corporation, United Therapeutics Corp, University of Minnesota, University of Southern California, vTitan Corporation Pvt Ltd, and Zealand Pharma AS.

Market Report Overview

Key Segments Infusion Pumps, Implantable Infusion Pumps, Syringe Pumps, Infusion Disposable Sets, Volumetric Pumps, Ambulatory Infusion Pumps, Disposable Ambulatory Infusion Pumps, PCA Syringe Pumps, and Reusable Ambulatory Infusion Pumps
Key Territories United States, Europe, Israel, Japan, New Zealand, Singapore, South Africa, United Kingdom, Australia, Canada, Chile, Colombia, Ecuador, Brazil, Argentina, and Mexico
Key Regulatory Paths 510(k), CE, TGA, PMA, UKCA, HSA, MDL, Ninsho, INVIMA, de Novo, and ANVISA
Key Companies Adept Medical Ltd, Albireo Pharma Inc, Alnylam Pharmaceuticals Inc, AngioDynamics Inc, Arnali, LLC, Massachusetts Institute of Technology, Medical Device Creations Ltd., Medovate Ltd, Unilife Corporation, United Therapeutics Corp, University of Minnesota, University of Southern California, vTitan Corporation Pvt Ltd, and Zealand Pharma AS

Scope

This report provides:

  • Extensive coverage of the infusion systems under development
  • The report reviews details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of infusion systems and lists all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage

  • Identify and understand important and diverse types of infusion systems under development

  • Develop market-entry and market expansion strategies

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Adept Medical Ltd
Albireo Pharma Inc
Alnylam Pharmaceuticals Inc
AngioDynamics Inc
Arnali, LLC
Avoset Health Ltd
Baxter Healthcare Corp
Baxter International Inc
Becton Dickinson and Co
BioQ Pharma Inc
Caesarea Medical Electronics Ltd
CareFusion Corp
ClearLine MD
Cognos Therapeutics Inc
Debiotech SA
Edwards Lifesciences Corp
Eitan Medical
Eksigent Technologies, LLC
Eli Lilly and Co
EryDel SPA
Flowonix Medical Inc
Fluonic, Inc. (Inactive)
Fresenius Medical Care AG & Co KGaA
HAI Solutions Inc
Hospira Inc
ICU Medical Inc
Infusense Corp
Innofuse BV
Innovative Health Sciences LLC
Innovfusion Pte. Ltd.
Intarcia Therapeutics Inc
IRadimed Corp
LifeMedix, LLC
Lynntech Inc
Massachusetts Institute of Technology
Medical Device Creations Ltd.
Medovate Ltd
MonuMedical LLC
NexGen Medical Systems Inc
Palyon Medical Corp (Inactive)
Pavmed Inc
PRO-IV Medical Ltd
Ratio Inc
Rice University
Sensile Medical AG
Shift Labs Inc
SQ Innovation AG
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Starton Therapeutics Inc
SteadyMed Therapeutics Inc
StnDrd Infusion Corporation
Supernus Pharmaceuticals Inc
Terumo Corp
ToucheMedical Ltd.
TriSalus Life Sciences Inc
Turnpoint Medical Devices Inc
U-Needle BV
Unilife Corporation
United Therapeutics Corp
University of Minnesota
University of Southern California
vTitan Corporation Pvt Ltd
Zealand Pharma AS

Table of Contents

1 Table of Contents 3

|1.1 List of Tables 8

|1.2 List of Figures 13

2 Introduction 14

2.1 Infusion Systems Overview 14

3 Products under Development 15

3.1 Infusion Systems – Pipeline Products by Stage of Development 15

3.2 Infusion Systems – Pipeline Products by Segment 16

3.3 Infusion Systems – Pipeline Products by Territory 17

3.4 Infusion Systems – Pipeline Products by Regulatory Path 18

3.5 Infusion Systems – Pipeline Products by Estimated Approval Date 19

3.6 Infusion Systems – Ongoing Clinical Trials 20

4 Infusion Systems – Pipeline Products under Development by Companies 21

4.1 Infusion Systems Companies – Pipeline Products by Stage of Development 21

4.2 Infusion Systems – Pipeline Products by Stage of Development 24

5 Infusion Systems Companies and Product Overview 27

5.1 Adept Medical Ltd Company Overview 27

5.1.1 Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

5.2 Albireo Pharma Inc Company Overview 28

5.2.1 Albireo Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.3 Alnylam Pharmaceuticals Inc Company Overview 29

5.3.1 Alnylam Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.4 AngioDynamics Inc Company Overview 30

5.4.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.5 Arnali, LLC Company Overview 31

5.5.1 Arnali, LLC Pipeline Products & Ongoing Clinical Trials Overview 31

5.6 Avoset Health Ltd Company Overview 32

5.6.1 Avoset Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 32

5.7 Baxter Healthcare Corp Company Overview 33

5.7.1 Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 33

5.8 Baxter International Inc Company Overview 36

5.8.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.9 Becton Dickinson and Co Company Overview 38

5.9.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 38

5.10 BioQ Pharma Inc Company Overview 40

5.10.1 BioQ Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.11 Caesarea Medical Electronics Ltd Company Overview 43

5.11.1 Caesarea Medical Electronics Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

5.12 CareFusion Corp Company Overview 45

5.12.1 CareFusion Corp Pipeline Products & Ongoing Clinical Trials Overview 45

5.13 ClearLine MD Company Overview 46

5.13.1 ClearLine MD Pipeline Products & Ongoing Clinical Trials Overview 46

5.14 Cognos Therapeutics Inc Company Overview 47

5.14.1 Cognos Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 47

5.15 Debiotech SA Company Overview 48

5.15.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 48

5.16 Edwards Lifesciences Corp Company Overview 50

5.16.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 50

5.17 Eitan Medical Company Overview 51

5.17.1 Eitan Medical Pipeline Products & Ongoing Clinical Trials Overview 51

5.18 Eksigent Technologies, LLC Company Overview 52

5.18.1 Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 52

5.19 Eli Lilly and Co Company Overview 54

5.19.1 Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview 54

5.20 EryDel SPA Company Overview 55

5.20.1 EryDel SPA Pipeline Products & Ongoing Clinical Trials Overview 55

5.21 Flowonix Medical Inc Company Overview 58

5.21.1 Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 58

5.22 Fluonic, Inc. (Inactive) Company Overview 60

5.22.1 Fluonic, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 60

5.23 Fresenius Medical Care AG & Co KGaA Company Overview 61

5.23.1 Fresenius Medical Care AG & Co KGaA Pipeline Products & Ongoing Clinical Trials Overview 61

5.24 HAI Solutions Inc Company Overview 62

5.24.1 HAI Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.25 Hospira Inc Company Overview 63

5.25.1 Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.26 ICU Medical Inc Company Overview 65

5.26.1 ICU Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 65

5.27 Infusense Corp Company Overview 67

5.27.1 Infusense Corp Pipeline Products & Ongoing Clinical Trials Overview 67

5.28 Innofuse BV Company Overview 68

5.28.1 Innofuse BV Pipeline Products & Ongoing Clinical Trials Overview 68

5.29 Innovative Health Sciences LLC Company Overview 69

5.29.1 Innovative Health Sciences LLC Pipeline Products & Ongoing Clinical Trials Overview 69

5.30 Innovfusion Pte. Ltd. Company Overview 70

5.30.1 Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70

5.31 Intarcia Therapeutics Inc Company Overview 73

5.31.1 Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.32 IRadimed Corp Company Overview 75

5.32.1 IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview 75

5.33 LifeMedix, LLC Company Overview 76

5.33.1 LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 76

5.34 Lynntech Inc Company Overview 77

5.34.1 Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.35 Massachusetts Institute of Technology Company Overview 78

5.35.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 78

5.36 Medical Device Creations Ltd. Company Overview 81

5.36.1 Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81

5.37 Medovate Ltd Company Overview 82

5.37.1 Medovate Ltd Pipeline Products & Ongoing Clinical Trials Overview 82

5.38 MonuMedical LLC Company Overview 83

5.38.1 MonuMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 83

5.39 NexGen Medical Systems Inc Company Overview 84

5.39.1 NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 84

5.40 Palyon Medical Corp (Inactive) Company Overview 85

5.40.1 Palyon Medical Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 85

5.41 Pavmed Inc Company Overview 86

5.41.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.42 PRO-IV Medical Ltd Company Overview 91

5.42.1 PRO-IV Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

5.43 Ratio Inc Company Overview 92

5.43.1 Ratio Inc Pipeline Products & Ongoing Clinical Trials Overview 92

5.44 Rice University Company Overview 93

5.44.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 93

5.45 Sensile Medical AG Company Overview 94

5.45.1 Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview 94

5.46 Shift Labs Inc Company Overview 95

5.46.1 Shift Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 95

5.47 SQ Innovation AG Company Overview 96

5.47.1 SQ Innovation AG Pipeline Products & Ongoing Clinical Trials Overview 96

5.48 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 99

5.48.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 99

5.49 Starton Therapeutics Inc Company Overview 100

5.49.1 Starton Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 100

5.50 SteadyMed Therapeutics Inc Company Overview 101

5.50.1 SteadyMed Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 101

5.51 StnDrd Infusion Corporation Company Overview 103

5.51.1 StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview 103

5.52 Supernus Pharmaceuticals Inc Company Overview 104

5.52.1 Supernus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 104

5.53 Terumo Corp Company Overview 105

5.53.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 105

5.54 ToucheMedical Ltd. Company Overview 107

5.54.1 ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 107

5.55 TriSalus Life Sciences Inc Company Overview 108

5.55.1 TriSalus Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 108

5.56 Turnpoint Medical Devices Inc Company Overview 110

5.56.1 Turnpoint Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 110

5.57 U-Needle BV Company Overview 111

5.57.1 U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview 111

5.58 Unilife Corporation Company Overview 113

5.58.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 113

5.59 United Therapeutics Corp Company Overview 114

5.59.1 United Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 114

5.60 University of Minnesota Company Overview 116

5.60.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 116

5.61 University of Southern California Company Overview 117

5.61.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 117

5.62 vTitan Corporation Pvt Ltd Company Overview 118

5.62.1 vTitan Corporation Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 118

5.63 Zealand Pharma AS Company Overview 120

5.63.1 Zealand Pharma AS Pipeline Products & Ongoing Clinical Trials Overview 120

6 Infusion Systems- Recent Developments 121

6.1 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 121

6.2 Aug 16, 2022: Pavmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results 123

6.3 Aug 11, 2022: Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2022 126

6.4 Aug 04, 2022: KORU Medical Systems to Participate in Canaccord Genuity’s 42nd Annual Growth Conference 128

6.5 Aug 04, 2022: DURECT Reports Second Quarter 2022 Financial Results and Update of Programs 128

6.6 Aug 03, 2022: KORU Medical Systems Announces 2022 Second Quarter Financial Results 131

6.7 Aug 01, 2022: Cardinal Health Names Michelle Greene as Chief Information Officer 132

6.8 Jul 29, 2022: Iradimed Announces Second Quarter 2022 Financial Results 133

6.9 Jul 26, 2022: 3M Reports Second-Quarter 2022 Results 135

6.10 Jul 21, 2022: Edwards Lifesciences to Host Earnings Conference Call on July 28, 2022 137

6.11 Jul 21, 2022: Lilly Confirms Date and Conference Call for Second-Quarter 2022 Financial Results Announcement 137

6.12 Jul 20, 2022: KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022 137

6.13 Jul 18, 2022: Alnylam to Webcast Conference Call Discussing Second Quarter 2022 Financial Results 137

6.14 Jul 07, 2022: Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2022 on August 11 138

6.15 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 138

6.16 Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors 139

6.17 Jun 07, 2022: Teleflex launches new arrow pressure injectable midline catheter in Europe, the Middle East and Africa region 139

6.18 Jun 03, 2022: Lilly to Participate in Goldman Sachs Global Healthcare Conference 139

6.19 Jun 03, 2022: Eli Lilly announces its new president and general manager for Latam 140

6.20 Jun 02, 2022: Alnylam to Webcast Presentations at Upcoming June Investor Conferences 140

6.21 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 140

6.22 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 140

6.23 May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference 140

6.24 May 23, 2022: Edwards Lifesciences to Present at the Bernstein 38th Annual Strategic Decisions Conference 141

6.25 May 18, 2022: Dr. Brandee Pappalardo Joins Fresenius Kabi as Chief Medical Officer for North America 141

6.26 May 17, 2022: Fresenius successfully places bonds with a volume of

1.3 billion euros 142

6.27 May 12, 2022: PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results 142

6.28 May 10, 2022: Baxter to Host 2022 Investor Conference 145

6.29 May 10, 2022: 3M Annual Meeting Highlights Strong 2021, Investments for Future 145

6.30 May 06, 2022: Mary Lynne Hedley Elected to Lilly Board of Directors 146

6.31 May 05, 2022: Cardinal Health Reports Third Quarter Fiscal 2022 Results 147

6.32 May 03, 2022: Lilly to Participate in Bank of America Securities 2022 Healthcare Conference 149

6.33 May 02, 2022: Teleflex to Host Analyst & Investor Day on May 20, 2022 149

6.34 Apr 29, 2022: Iradimed Announces First Quarter 2022 Financial Results 150

6.35 Apr 29, 2022: Iradimed Corporation Announces First Quarter 2022 Financial Results 151

6.36 Apr 28, 2022: Teleflex Reports First Quarter Financial Results And Full Year Outlook 151

6.37 Apr 28, 2022: Iradimed Announces Executive Transition 153

6.38 Apr 19, 2022: Edwards Lifesciences to Host Earnings Conference Call on April 26, 2022 153

6.39 Apr 18, 2022: KORU Medical Systems Appoints Brian Case As Chief Technology Officer 153

6.40 Apr 14, 2022: Alnylam to Webcast Conference Call Discussing First Quarter 2022 Financial Results 154

6.41 Mar 30, 2022: ConvaTec Group announces Annual Report and Accounts 2021 and Notice of AGM 154

6.42 Mar 24, 2022: Novo Nordisk Announces Resolutions from the Annual General Meeting 154

6.43 Mar 24, 2022: Resolutions from the Annual General Meeting of Novo Nordisk 156

6.44 Mar 23, 2022: DURECT Corp. to Present at the 2022 Cantor Fitzgerald Virtual Rare Orphan Disease Summit 157

6.45 Mar 17, 2022: ConvaTec Group Announces Board Change 157

6.46 Mar 10, 2022: PAVmed Subsidiary Veris Health Launches World-Class Technology Advisory Board 157

6.47 Mar 08, 2022: ConvaTec Group Annual Results for the twelve months ended 31 December 2021 159

6.48 Mar 08, 2022: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2021 160

6.49 Mar 07, 2022: Durect Reports Fourth Quarter and Full Year 2021 Financial Results and Update of Programs 164

6.50 Mar 02, 2022: KORU Medical Systems Announces 2021 Q4 and Full Year Financial Results 165

6.51 Feb 28, 2022: American Oncology Network partners with InfuSystem to provide patients ambulatory infusion pumps 167

6.52 Feb 28, 2022: Alnylam to Webcast Presentations at Upcoming March Investor Conferences 168

6.53 Feb 24, 2022: Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results 168

6.54 Feb 24, 2022: PAVmed Appoints Shaun O’Neil as Chief Operating Officer 169

6.55 Feb 22, 2022: CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022 170

6.56 Feb 21, 2022: Notice for the Annual General Meeting of Novo Nordisk 170

6.57 Feb 16, 2022: Koru Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2 2021 171

6.58 Feb 16, 2022: Raumedic appoints new CEO at its U.S. headquarters 171

6.59 Feb 15, 2022: Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors 172

6.60 Feb 10, 2022: Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results 172

6.61 Feb 10, 2022: TriSalus Life Sciences expands clinical executive team and scientific advisors in support of company’s focus to overcome liver and pancreatic cancer treatment barriers and enable more patients to benefit from immunotherapy 177

6.62 Feb 10, 2022: Baxter to Present at Citi’s 2022 Virtual Healthcare Conference 178

6.63 Feb 08, 2022: Alnylam to Webcast Presentation at 11th Annual SVB Leerink Global Healthcare Conference 178

6.64 Feb 04, 2022: Iradimed Announces Fourth Quarter 2021 Financial Results 179

6.65 Feb 03, 2022: Cardinal Health Reports Second Quarter Fiscal 2022 Results 181

6.66 Jan 31, 2022: Poly Medicure Announces Unaudited Financial Results for the Quarter and Nine Month Ended December 31 2021 182

6.67 Jan 31, 2022: Poly Medicure Announces Statement of Unaudited Standalone Financial Results for the Quarter and Nine Months Ended December 31 2021 183

6.68 Jan 27, 2022: ConvaTec Group Announce Board Committee Changes 184

6.69 Jan 25, 2022: 3M Reports Fourth-Quarter and Full-Year 2021 Results 184

6.70 Jan 22, 2022: 3M MMM to Release Earnings on Tuesday 187

6.71 Jan 19, 2022: Edwards Lifesciences to Host Earnings Conference Call on January 26, 2022 187

6.72 Jan 13, 2022: Fort HealthCare partners with Ivenix to provide unprecedented infusion safety 187

6.73 Jan 09, 2022: Alnylam Announces Preliminary Fourth Quarter and Full Year 2021 Global Net Product Revenues and Provides Additional Updates 187

6.74 Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors 188

6.75 Jan 05, 2022: Edwards Lifesciences to Present at the 40th Annual JP Morgan Healthcare Conference 189

6.76 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 189

6.77 Jan 03, 2022: Alnylam to Webcast Presentation at 40th Annual JP Morgan Healthcare Conference 189

6.78 Dec 14, 2021: DURECT Expands Board of Directors with Appointment of Biopharmaceutical Industry Finance Veteran Peter Garcia 189

6.79 Dec 13, 2021: Fresenius Kabi modernizes production facility in France 190

6.80 Dec 09, 2021: Convatec Announces Chief Financial Officer succession 190

6.81 Dec 08, 2021: Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference 191

6.82 Dec 08, 2021: Baxter presents data at ASHP meeting indicating machine learning may enhance infusion pump programming safety 192

6.83 Nov 18, 2021: Teleflex to Participate in the 33rd Annual Virtual Piper Sandler Healthcare Conference 193

6.84 Nov 18, 2021: MicroPort RehabTech TherMotion Cryo-Thermo compression device approved for marketing in China 193

6.85 Nov 16, 2021: PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results 194

6.86 Nov 09, 2021: Cardinal Health Reports First Quarter Fiscal 2022 Results 196

6.87 Nov 09, 2021: KORU Medical Systems to Participate in Two Upcoming Conferences 198

6.88 Nov 08, 2021: KORU Medical announces collaboration with Gilero to accelerate innovation 198

6.89 Nov 04, 2021: Terumo Corp Half Yearly Results For the Period 30 September 2021 199

6.90 Nov 03, 2021: Novo Nordisk’s net profit increased by 12% in the first nine months of 2021 199

6.91 Nov 02, 2021: Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference 199

6.92 Nov 02, 2021: DURECT Corporation Reports financial results for the three months ended September 30, 2021 199

6.93 Nov 01, 2021: Poly Medicure announces Unaudited Financial Results Standalone & Consolidated for the Second quarter and half year ended on 30th September 2021 200

6.94 Oct 29, 2021: Iradimed Announces Third Quarter 2021 Financial Results 201

6.95 Oct 29, 2021: Veris Health Showcased in PAVmed Digital Health Virtual Investor Event 203

6.96 Oct 28, 2021: Teleflex Reports Third Quarter 2021 Results and Full Year Outlook 203

6.97 Oct 28, 2021: Alimera Sciences Announces Third Quarter 2021 Financial Results 207

6.98 Oct 28, 2021: Alnylam Announces Planned CEO Leadership Transition 209

6.99 Oct 27, 2021: KORU Medical Systems to Report Third Quarter 2021 Financial Results on November 10, 2021 210

6.100 Oct 26, 2021: KORU Medical Appoints Chris Pazdan as Vice President of Quality Assurance and Regulatory Affairs 210

6.101 Oct 26, 2021: 3M Reports Third-Quarter 2021 Results 211

6.102 Oct 14, 2021: Teleflex Announces Third Quarter 2021 Earnings Conference Call Information 213

6.103 Oct 14, 2021: Alnylam to Webcast Conference Call Discussing Third Quarter 2021 Financial Results 214

6.104 Oct 13, 2021: Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference 214

6.105 Oct 07, 2021: Construction begins on 280,000-square-meter MicroPort MegaFactory and global medical experience center 214

6.106 Oct 05, 2021: Moog Reports Fiscal Year End 2021 Results and Initial Guidance for Fiscal Year 2022 215

6.107 Sep 27, 2021: Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors 216

6.108 Sep 21, 2021: PAVmed subsidiary Veris Health joins Microsoft for startups global program and engages Loka as software development partner 216

6.109 Sep 06, 2021: Anteris appoints chief medical officer 217

6.110 Sep 01, 2021: Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference 218

6.111 Aug 31, 2021: Lilly to Participate in Citi’s 16th Annual BioPharma Virtual Conference 218

7 Appendix 219

7.1 Methodology 219

7.2 About GlobalData 222

7.3 Contact Us 222

7.4 Disclaimer 222

Frequently asked questions

Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Drug Delivery Devices reports
Medical Devices
India Surgical Energy Instruments Market Size (Value, Volume, ASP) by…
$500 | April 2018
Medical Devices
Japan Surgical Energy Instruments Market Size (Value, Volume, ASP) by…
$500 | April 2018
Medical Devices
New Zealand Surgical Energy Instruments Market Size (Value, Volume, ASP)…
$500 | April 2018
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update in real time.

  • Access a live Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more